Literature DB >> 210972

Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.

A Nordøy, B Svensson, D Wiebe, J C Hoak.   

Abstract

We investigated the effect of plasma low density lipoproteins (LDL), very low density lipoproteins (VLDL), and high density lipoproteins (HDL) on the platelet inhibitory effect of primary cultures of human endothelial cell monolayers (ECM). ECM incubated with lipoprotein-deficient plasma (LDP) for 2 hours at 37 degrees C had an inhibitory effect on ADP- and collagen-induced platelet aggregation and prostaglandin production in platelet-rich plasma similar to that observed when ECM were preincubated with growth medium or plasma. Concentrations of LDL in LDP up to protein concentration of 1600 microgram/ml had an inhibitory effect on the endothelial cells' ability to modulate these platelet reactions. VLDL at the highest concentration (1600 microgram/ml) had a slightly inhibitory effect, whereas HDL showed no such effect. The inhibitory effect of LDL was not observed during the first hour of incubation. When HDL in concentrations similar to or higher than LDL were combined with LDL, the inhibitory effect of LDL was partially reduced. VLDL combined with LDL or HDL did not interfere with the effects of the later fractions. The inhibitory effect of LDL was significantly reduced when LDL were diluted in whole plasma. Prostacyclin which is synthesized and released from the endothelial cells and contributes to the inhibitory effect upon platelets did not change its effect on platelet reactivity by preincubation with the various lipoprotein fractions. The current studies may indicate that LDL have a direct effect on the endothelial cells and that this effect may be partially counteracted by HDL. This effect of LDL on the endothelial cells reduces the endothelium's ability to inhibit platelet aggregation and thus could favor the tendency to thrombus formation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210972     DOI: 10.1161/01.res.43.4.527

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  9 in total

1.  Effects of LDL and HDL on morphology of and prostacyclin synthesis in cultured vascular endothelial cells.

Authors:  S M Wei; W H Ren; Z Y Wang
Journal:  J Tongji Med Univ       Date:  1987

Review 2.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

3.  Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men.

Authors:  R Rauramaa; J T Salonen; K Kukkonen-Harjula; K Seppänen; E Seppälä; H Vapaatalo; J K Huttunen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-25

Review 4.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

5.  Diet-induced hypercholesterolemia inhibits the recovery of prostacyclin production by injured rabbit aorta.

Authors:  A Eldor; D J Falcone; D P Hajjar; C R Minick; B B Weksler
Journal:  Am J Pathol       Date:  1982-05       Impact factor: 4.307

6.  Plasma factors influencing PGI2-like activity in patients with IgA nephropathy and Henoch-Schönlein purpura.

Authors:  S Túri; J Nagy; I Haszon; Z Havass; M Németh; C Bereczki
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

7.  Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells.

Authors:  S Aanderud; H Krane; A Nordøy
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

8.  Effect of ethanol on low density lipoprotein and platelet composition.

Authors:  J L Hojnacki; J E Cluette-Brown; R N Deschenes; J J Mulligan; T V Osmolski; N J Rencricca; J J Barboriak; J A Jakubowski
Journal:  Lipids       Date:  1991-11       Impact factor: 1.880

9.  Prostacyclin and blood coagulation.

Authors:  S Moncada; J R Vane
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.